Pirfenidone (PFD) is a pharmacological compound with therapeutic efficacy in idiopathic
pulmonary fibrosis. It has been chiefly characterized as an antifibrotic agent, although it was …

Acute exacerbations of chronic obstructive pulmonary disease (COPD) are associated with a
significant mortality, health and economic burden. Their diagnosis, assessment and …

Anticipation of clinical decompensation is essential for effective emergency and critical care.
In this study, we develop a multimodal machine learning approach to predict the onset of …

Background Influenza vaccinations are currently recommended in the care of people with
COPD, but these recommendations are based largely on evidence from observational …

Background Fatigue is a main or secondary reason for 10–20% of all consultations with a
primary care physician. Methods This review is based on pertinent publications retrieved by …

Current management strategies for chronic obstructive pulmonary disease (COPD)
incorporate a step-wise, multidisciplinary approach to effectively manage patient symptoms …

Introduction Chronic obstructive pulmonary disease (COPD) is a treatable and preventable
disease characterised by persistent respiratory symptoms and chronic airflow limitation on …

Chronic obstructive pulmonary disease (COPD) and lung cancer are major lung diseases
affecting millions worldwide. Both diseases have links to cigarette smoking and exert a …

Inhaled bronchodilators (alone or in combination) are the cornerstone of treatment for
symptomatic patients with COPD, either as initial/first-line treatment or for second …